EValuate Diagnostics, Inc.
PrivateLast Round
Seed
Feb 8, 2024
Total Funding Raised
$1M
Company Overview
EValuate Diagnostics, Inc. operates in Healthcare & Life Sciences and is based in Edison, New Jersey. Its latest recorded funding round was a Seed round in February 2024.
EValuate Diagnostics, Inc. is a biotechnology company that develops a diagnostic platform for the targeted capture of circulating biomarkers, such as extracellular vesicles, to enable the early detection of tumors and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EValuate Diagnostics, Inc. Comparables
Compare EValuate Diagnostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mercy BioAnalytics | 81% | |
| Mursla Bio | 81% | |
| Exosomics S.p.A. | 80% |
For institutional investors. Book with your work email.
EValuate Diagnostics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
EValuate Diagnostics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hackensack Meridian Health | Seed |
| Foundation Venture Capital Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 8, 2024
$1M round led by Foundation Venture Capital Group
For institutional investors. Book with your work email.
EValuate Diagnostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EValuate Diagnostics, Inc.'s valuation, stock price, and market status.
Is EValuate Diagnostics, Inc. a public or private company?
EValuate Diagnostics, Inc. is a private company.
What is the current stock price of EValuate Diagnostics, Inc.?
EValuate Diagnostics, Inc. is a private company, so its shares have no public market price. Caplight tracks EValuate Diagnostics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EValuate Diagnostics, Inc. worth (valuation)?
Valuation information for EValuate Diagnostics, Inc. is not publicly available.
Can I buy EValuate Diagnostics, Inc. stock?
EValuate Diagnostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EValuate Diagnostics, Inc.'s last funding round?
EValuate Diagnostics, Inc.'s most recent funding round was Seed on February 8, 2024.
Who are the main investors in EValuate Diagnostics, Inc.?
Key investors in EValuate Diagnostics, Inc. include Foundation Venture Capital Group.
Will EValuate Diagnostics, Inc. IPO soon?
No public IPO plans have been announced for EValuate Diagnostics, Inc..
How can I track EValuate Diagnostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in EValuate Diagnostics, Inc.'s shares on secondary markets.